Embody vs Ro
This is the clearest example of the two roads into GLP-1 treatment. Embody is a cash-pay compounding route built for low, predictable pricing — $69/mo semaglutide, $119/mo tirzepatide, flat. Ro is a branded route built around FDA-approved medication and insurance, where your real cost depends almost entirely on your coverage. Below we put actual numbers to both.
Last reviewed 2026-09-01 · Pricing is provider-reported and changes often — confirm current rates on each provider's site. We may earn a commission.
Educational, not medical advice. This page explains GLP-1 medications in general terms. Only a licensed clinician who knows your history can decide what's right for you.
Embody's flat, cash-price GLP-1 is the realistic pick for most people — the only reason to choose Ro is if your insurance genuinely covers branded GLP-1.
View Plan: embodyChoose embody if…
you're paying cash and want the lowest, most predictable monthly price with fast shipping.
Choose Ro if…
you want an FDA-approved branded medication and think your insurance may cover it.
Cost breakdown
The numbers that actually decide it, side by side.
| | |
|---|---|---|
| Semaglutide, month 1 | $69 (flat) | Insurance copay, or ~$1,000+ cash |
| Semaglutide, ongoing monthly | $69/mo flat | Depends on insurance; high without it |
| Tirzepatide, ongoing monthly | $119/mo flat | Depends on insurance; high without it |
| ~6-month semaglutide (cash, no insurance) | ~$414 | Potentially $6,000+ at branded cash list |
| Shipping | Free 1–2 day | Via pharmacy; varies |
| What you get | Compounded (not FDA-approved finished drug) | FDA-approved branded medication |
The gap here is driven by the product type, not a discount war. Embody dispenses compounded semaglutide and tirzepatide, which sidesteps the branded list price entirely — so it can charge a flat $69–$119 a month, cash. Ro dispenses the branded, FDA-approved drugs (Wegovy, Zepbound, Ozempic, Mounjaro), whose cash list price sits near $1,000+/month before any insurance or manufacturer savings.
That means the two are only comparable once you know your insurance situation. If your plan covers GLP-1 for weight loss, Ro can get you a branded medication for an insurance copay that may undercut cash compounding — and you get an FDA-approved finished product. If your plan excludes weight-loss GLP-1 (extremely common), Ro's route can cost many times what Embody charges, and Embody becomes the realistic way to actually start.
One honest caveat on Embody's side: compounded medications are not FDA-approved finished products, and the FDA has flagged risks with unapproved and poorly made compounds. Embody mitigates this by using 503A pharmacies and stating LegitScript certification — but the trade-off for the low price is real and worth understanding.
Full specs, side by side
| | |
|---|---|---|
| Starting price | $69/mo (compounded semaglutide) | Membership + medication (insurance-dependent) |
| Compounded semaglutide | $69/mo flat (compounded) | Brand Wegovy / Ozempic (price depends on insurance) |
| Tirzepatide | $119/mo flat (compounded) | Brand Zepbound / Mounjaro (price depends on insurance) |
| GLP-1 + GIP option | Yes — tirzepatide is a GLP-1/GIP dual agonist, $119/mo | Yes — brand tirzepatide (Zepbound/Mounjaro) |
| Offering type | Compounded | Branded |
| New-patient offer | Flat pricing (no intro-then-hike model) | Varies by promotion |
| Billing model | Monthly, flat rate | Membership plus medication cost |
| What's included | Visit with licensed doctor, Medication, Free 1–2 day shipping | Clinician review, Ongoing support, Insurance navigation |
| Lab work | Online intake | May be required depending on plan |
| Shipping | Free 1–2 day shipping | Via partner/retail pharmacy |
| Refills | Monthly refills | Per prescription |
| States | Most US states | Nationwide |
| Pharmacy | 503A pharmacies; LegitScript-certified | Licensed retail/mail pharmacies (FDA-approved branded drugs) |
| Clinicians | US-licensed doctors | US-licensed clinicians |
| Insurance | Cash only | Works with insurance |
| Consultation | Online visit with licensed doctors | Clinician-reviewed treatment plan |
| Our rating | 9.9 · Exceptional | 9.5 · Excellent |
Medications & formulations
- Embody offers compounded semaglutide (the molecule in Wegovy/Ozempic) and compounded tirzepatide (the GLP-1/GIP molecule in Zepbound/Mounjaro). Same active ingredients as the brands; different manufacturing and oversight.
- Ro offers the branded, FDA-approved versions and can help route you to the right one based on your diagnosis and insurance — an advantage if you specifically want an FDA-reviewed finished product.
New to the drugs themselves? Read our plain-language guides to semaglutide and tirzepatide.
Pros & cons
Pros
- Flat, published pricing with no tiers to decode
- Both semaglutide and tirzepatide offered
- Free 1–2 day shipping
- LegitScript certification and 503A pharmacies stated upfront
Cons
- Compounded only — no brand-name Wegovy/Zepbound
- Cash-pay only (no insurance billing)
Pros
- Access to FDA-approved branded GLP-1 (Wegovy, Zepbound, Ozempic, Mounjaro)
- Insurance coordination and prior-auth help
- Large, established telehealth platform
- Clinician review on every plan
Cons
- Can be expensive without insurance coverage
- Membership fee on top of medication
- Branded supply can be affected by shortages
Where each one has the edge
We don't tally a winner — that hides the trade-offs. Here's who leads on each dimension and why.
Embody's flat $69/mo semaglutide is far below branded cash pricing.
Ro dispenses branded, FDA-approved GLP-1; Embody is compounded.
Ro is built to work with insurance; Embody is cash-only.
Embody publishes flat prices; Ro's cost hinges on your coverage.
Embody advertises free 1–2 day shipping.
Match by your priority
The fastest way to decide: find your top priority, see which program we'd point you to.
If your priority is You want the lowest cash price
If your priority is Your insurance likely covers GLP-1
If your priority is You specifically want brand-name Wegovy or Zepbound
If your priority is You want predictable, no-surprises billing
Embody vs Ro: common questions
The bottom line
If your insurance covers GLP-1, Ro's branded route is compelling and gives you an FDA-approved product. If it doesn't — which is common for weight loss — Embody's flat compounded pricing is the pragmatic way to actually start treatment, at roughly a tenth of branded cash cost.
How we compare — and how to read this
We compare programs on the factors that actually affect a patient: real price (including whether it's compounded or branded), medications and formulations offered, shipping, pharmacy accreditation and clinician model, insurance stance, and commitment. We name a top pick for most people, but we show the trade-offs in full so you can override it when your priorities or insurance point the other way. Pricing is provider-reported and changes frequently — and compounded-drug availability shifts with FDA shortage status — so always confirm the current details on the provider's own site before enrolling. Affiliate relationships do not change a program's placement. This page is educational and not medical advice; see our disclaimer.